[HTML][HTML] Monkeypox: An emerging global threat during the COVID-19 pandemic

CC Lai, CK Hsu, MY Yen, PI Lee, WC Ko… - Journal of Microbiology …, 2022 - Elsevier
The emergence of the monkeypox outbreak in early 2022 has posed a new global health
threat. As of July 8, 2022, 9069 laboratory-confirmed cases have been reported, and most of …

[HTML][HTML] Long COVID: An inevitable sequela of SARS-CoV-2 infection

CC Lai, CK Hsu, MY Yen, PI Lee, WC Ko… - Journal of Microbiology …, 2023 - Elsevier
At present, there are more than 560 million confirmed cases of the coronavirus disease 2019
(COVID-19) worldwide. Although more than 98% of patients with severe acute respiratory …

Omicron variant of SARS-CoV-2: An Indian perspective of vaccination and management

VP Chavda, P Balar, D Vaghela, HK Solanki… - Vaccines, 2023 - mdpi.com
Omicron variants have highly influenced the entire globe. It has a high rate of
transmissibility, which makes its management tedious. There are various subtypes of …

Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks …

AMC Rose, N Nicolay, VS Martín… - …, 2023 - eurosurveillance.org
Introduction The I-MOVE-COVID-19 and VEBIS hospital networks have been measuring
COVID-19 vaccine effectiveness (VE) in participating European countries since early 2021 …

SARS-CoV-2 evolved variants optimize binding to cellular glycocalyx

SH Kim, FL Kearns, MA Rosenfeld, L Votapka… - Cell Reports Physical …, 2023 - cell.com
Viral variants of concern continue to arise for SARS-CoV-2, potentially impacting both
methods for detection and mechanisms of action. Here, we investigate the effect of an …

The importance of booster vaccination in the context of Omicron wave

Z Wei, J He, C Wang, J Bao, T Leng… - Frontiers in …, 2022 - frontiersin.org
Omicron (B. 1.1. 529) was first detected in a sample collected in Botswana on November 11,
2021, and has rapidly replaced Delta as the dominant global variant given the robust …

Coronavirus disease 2019 rebounds following nirmatrelvir/ritonavir treatment

CC Lai, PR Hsueh - Journal of Medical Virology, 2023 - Wiley Online Library
Abstract Nirmatrelvir/ritonavir (NMV‐r) is an effective anti‐SARS‐CoV‐2 agent and has been
recommended in the treatment of nonhospitalized patients with COVID‐19. In rare …

Factors associated with COVID-19 vaccination coverage in hypertensive patients with Omicron infection in Shanghai, China

K Zhu, S Ma, H Chen, J Xie, D Huang… - Human Vaccines & …, 2023 - Taylor & Francis
The potential future burden of COVID-19 is determined by the level of susceptibility of the
population to infection. The protective effect provided by those previously infected …

Density functional modeling, and molecular docking with SARS-CoV-2 spike protein (Wuhan) and omicron S protein (variant) studies of new heterocyclic compounds …

S Akman, S Akkoc, CT Zeyrek… - Journal of …, 2023 - Taylor & Francis
Nowadays, different vaccines and antiviral drugs have been developed and their
effectiveness has been proven against SARS-CoV-2. Pyrazoline derivatives are biologically …

Effectiveness of COVID-19 vaccines against ICU admission during Omicron surge in Saudi Arabia: a nationwide retrospective cohort study

S Aldawish, R Abusaris, E Almohammadi… - BMC Infectious …, 2023 - Springer
Introduction Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused
significant economic damage and forced a slew of limitations to be placed by regulatory …